Related Experiment Video

Updated: Oct 9, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease

C Herold1, R Heinz, M Radespiel-Tröger

  • 1Dept of Medicine I, University of Erlangen-Nuernberg, Germany. christoph.herold@med1.med.uni-erlangen.de

Liver
|February 13, 2001
PubMed

Insights

Quantitative testing of liver function (QTLF) shows decreased metabolic function in hepatitis C cirrhosis patients, correlating with disease severity. These tests may predict prognosis in early-stage cirrhosis.

Area of Science:

  • Hepatology
  • Diagnostic Medicine
  • Biomarkers

Background:

  • Quantitative testing of liver function (QTLF) offers prognostic insights for liver diseases.
  • Limited data exists on QTLF in hepatitis C-induced cirrhosis.

Purpose of the Study:

  • To assess the utility of QTLF in patients with hepatitis C-related cirrhosis.
  • To correlate QTLF results with Child-Pugh classification.

Main Methods:

  • 86 patients with confirmed hepatitis C cirrhosis underwent liver biopsy.
  • QTLF included aminopyrine breath test, galactose elimination capacity, sorbitol clearance, and indocyanine green clearance.
  • Results were analyzed against Child-Pugh grades (A, B, C).

Main Results:

  • QTLF values decreased progressively from Child-Pugh grade A to C.
  • Metabolic liver function tests were significantly reduced, while hepatic perfusion tests were near the lower normal limit in Child-Pugh A.
  • All QTLF were significantly lower in grades B and C compared to controls.

Conclusions:

  • QTLF inversely correlates with Child-Pugh grades in hepatitis C cirrhosis.
  • QTLF, particularly metabolic function tests, may predict prognosis and complications in early cirrhosis.
Abstract

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...